Miller KD, Nogueira L, Devasia T et al (2022) Cancer treatment and survivorship statistics, 2022. CA A Cancer J Clin 72:409–436
van Atteveld JE, de Winter DT, Pluimakers VG et al (2023) Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study. Lancet Diabetes Endocrinol 11:21–32
Wilson CL, Ness KK (2013) Bone mineral density deficits and fractures in survivors of childhood cancer. Curr Osteoporos Rep 11:329–337
Article PubMed PubMed Central Google Scholar
Morales JS, Valenzuela PL, Rincón-Castanedo C, Santos-Lozano A, Fiuza-Luces C, Lucia A (2019) Is health status impaired in childhood cancer survivors? A systematic review and meta-analysis. Crit Rev Oncol Hematol 142:94–118
Weber DR, Boyce A, Gordon C et al (2019) The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position. J Clin Densitom 22:567–589
Article PubMed PubMed Central Google Scholar
Leslie WD, Adler RA, Fuleihan GE-H et al (2006) Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions. J Clin Densitom 9:22–30
Shepherd JA (2023) Positions of The International Society for Clinical Densitometry and Their Etiology: a scoping review. J Clin Densitom 26:101369
van Atteveld JE, Mulder RL, van den Heuvel-Eibrink MM et al (2021) Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Diabetes Endocrinol 9:622–637
Article PubMed PubMed Central Google Scholar
Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR (2008) Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics 121:e705–e713
Furlan AD, Pennick V, Bombardier C, van Tulder M (2009) 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 34:1929–1941
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W-65-W−94
Page MJ, McKenzie JE, Bossuyt PM et al (2020) Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines. J Clin Epidemiol 118:60–68
Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
Article CAS PubMed Google Scholar
Yamashita N, Tanaka H, Moriwake T, Nishiuchi R, Oda M, Seino Y (2003) Analysis of linear growth in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Metab 21:172–178
Barr R, Simpson T, Webber C et al (1998) Osteopenia in children surviving brain tumours. Eur J Cancer 34:873–877
Article CAS PubMed Google Scholar
Mostoufi-Moab S, Kelly A, Mitchell JA et al (2018) Changes in pediatric DXA measures of musculoskeletal outcomes and correlation with quantitative CT following treatment of acute lymphoblastic leukemia. Bone 112:128–135
Article PubMed PubMed Central Google Scholar
Jarfelt M, Fors H, Lannering B, Bjarnason R (2006) Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 154:303–309
Article CAS PubMed Google Scholar
Follin C, Link K, Wiebe T, Moëll C, Björk J, Erfurth EM (2011) Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without GH therapy. Eur J Endocrinol 164:695–703
Article CAS PubMed Google Scholar
Mäkitie O, Heikkinen R, Toiviainen-Salo S, Henriksson M, Puukko-Viertomies L-R, Jahnukainen K (2013) Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study. Eur J Endocrinol 168:281–288
Brennan B, Rahim A, Adams J, Eden O, Shalet S (1999) Reduced bone mineral density in young adults following cure of acute lympblastic leukaemia in childhood. Br J Cancer 79:1859–1863
Article CAS PubMed PubMed Central Google Scholar
Choi HS, Chang EJ, Lee EH, Yang HR (2017) Changes in bone health during the first year of cancer treatment in children. J Clin Densitom 20:25–31
El-Ziny MA, Al-Tonbary YA, Salama OS, Bakr A, Al-Marsafawy H, Elsharkawy AA (2007) Low bone mass in children with malignant lymphoma. Pediatr Hematol Oncol 24:577–585
El-Ziny MA, Al-Tonbary YA, Salama OS, Bakr AA, Al-Marsafawy H, Elsharkawy AA (2005) Low turnover bone disease in Egyptian children with acute leukemia. Hematology 10:327–333
Dubnov-Raz G, Azar M, Reuveny R, Katz U, Weintraub M, Constantini NW (2015) Changes in fitness are associated with changes in body composition and bone health in children after cancer. Acta Paediatr 104:1055–1061
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135
Article PubMed PubMed Central Google Scholar
Le Meignen M, Auquier P, Barlogis V et al (2011) Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities. Blood J Am Soc Hematol 118:1481–1489
Petryk A, Polgreen LE, Zhang L et al (2014) Bone mineral deficits in recipients of hematopoietic cell transplantation: the impact of young age at transplant. Bone Marrow Transplant 49:258–263
Article CAS PubMed Google Scholar
Maniadaki I, Stiakaki E, Germanakis I, Kalmanti M (2006) Evaluation of bone mineral density at different phases of therapy of childhood all. Pediatr Hematol Oncol 23:11–18
Polgreen LE, Petryk A, Dietz AC et al (2012) Modifiable risk factors associated with bone deficits in childhood cancer survivors. BMC Pediatr 12:1–9
Arikoski P, Komulainen J, Riikonen P, Jurvelin JS, Voutilainen R, Kröger H (1999) Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child 80:143–148
Article CAS PubMed PubMed Central Google Scholar
Altman DG, Bland JM (2005) Standard deviations and standard errors. Bmj 331:903
Article PubMed PubMed Central Google Scholar
Arikoski P, Komulainen J, Riikonen P et al (1999) Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res 14:2002–2009
Article CAS PubMed Google Scholar
Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions.
Vitanza NA, Hogan LE, Zhang G, Parker RI (2015) The progression of bone mineral density abnormalities after chemotherapy for childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 37:356–361
Article CAS PubMed Google Scholar
van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM (2002) Altered bone mineral d
Comments (0)